Dashboard
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -14.68% and Operating profit at -157.71% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 6.97% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -14.68% and Operating profit at -157.71% over the last 5 years
3
With a fall in Net Sales of -80.71%, the company declared Very Negative results in Sep 25
4
Risky -
Stock DNA
Pharmaceuticals & Biotechnology
CNY 608 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.23
-1.55%
0.50
Revenue and Profits:
Net Sales:
50 Million
(Quarterly Results - Mar 2026)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.63%
0%
-2.63%
6 Months
8.5%
0%
8.5%
1 Year
31.34%
0%
31.34%
2 Years
13.26%
0%
13.26%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Sichuan Gangtong Medical Equipment Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-14.68%
EBIT Growth (5y)
-157.71%
EBIT to Interest (avg)
25.86
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.55
Tax Ratio
10.41%
Dividend Payout Ratio
165.18%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.22%
ROE (avg)
6.97%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.69
EV to EBIT
-65.99
EV to EBITDA
-138.11
EV to Capital Employed
1.98
EV to Sales
2.94
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.00%
ROE (Latest)
-0.95%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
50.50
24.30
107.82%
Operating Profit (PBDIT) excl Other Income
-2.00
4.20
-147.62%
Interest
1.50
1.60
-6.25%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.50
1.60
-193.75%
Operating Profit Margin (Excl OI)
-40.00%
32.70%
-7.27%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 107.82% vs -68.07% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is -193.75% vs -85.05% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
750.90
839.00
-10.50%
Operating Profit (PBDIT) excl Other Income
13.10
76.10
-82.79%
Interest
7.00
4.70
48.94%
Exceptional Items
2.10
-0.30
800.00%
Consolidate Net Profit
14.40
83.10
-82.67%
Operating Profit Margin (Excl OI)
0.20%
79.00%
-7.88%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -10.50% vs 9.52% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -82.67% vs 12.45% in Dec 2023
About Sichuan Gangtong Medical Equipment Group Co., Ltd. 
Sichuan Gangtong Medical Equipment Group Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






